Utility of neuromodulation, mindfulness and person-centered therapy in chronic low back pain

ISRCTN ISRCTN91142724
DOI https://doi.org/10.1186/ISRCTN91142724
Secondary identifying numbers SRHU/Ph.D.Cell/Sup/2023-14
Submission date
21/09/2025
Registration date
25/09/2025
Last edited
24/09/2025
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Low back pain (LBP) is a widespread public health issue with significant socioeconomic implications globally, affecting individuals across all age groups. Non-specific chronic low back pain (NSCLBP) is diagnosed after ruling out serious spinal pathology or nerve root involvement using clinical red flags and imaging such as X-rays or MRI scans. NSCLBP is among the leading causes of physician visits and disability, often resulting in missed work and reduced physical function, particularly in individuals under 45 years of age. This study aims to compare the effects of transcranial direct current stimulation (tDCS), mindfulness-based stress reduction therapy (MBSR), and cognitive functional therapy (CFT) as adjuvant therapy with standard medical treatment in patients with NSCLBP.

Who can participate?
Patients aged 20 to 55 years with NSCLBP

What does the study involve?
Participants were randomly allocated to one of four groups:
Group 1: standard medical treatment (pharmacological) (pain modification treatment)
Group 2: standard medical treatment and tDCS for 20 min 5 days per week for 2 consecutive weeks
Group 3: standard medical treatment and group therapy was given to the participants in two groups (15 participants in each group). Duration of each session was between 90-120 minutes. Sessions were given weekly. A total of 8-10 sessions was given.
Group 4: standard medical treatment and individually tailored CFT sessions were given to the patients. Sessions ranged from 8-12 sessions over a period of 12 weeks.

What are the possible benefits and risks of participating?
The potential benefits include reduction in pain and disability and improved overall wellbeing of the participants. Risks associated with the study are potential adverse effects of medication and tDCS.

Where is the study run from?
Swami Rama Himalayan University (India)

When is the study starting and how long is it expected to run for?
February 2022 to March 2025

Who is funding the study?
Swami Rama Himalayan University (India)

Who is the main contact?
Vithika Singh, ptvithikasingh@gmail.com

Contact information

Dr Vithika Singh
Public, Scientific, Principal investigator

Research Cell, Department of Brain and Mind Sciences
Swami Rama Himalayan University
Dehradun
248016
India

Phone +91 (0)9540246442
Email ptvithikasingh@gmail.com

Study information

Study designSingle-centre interventional open-label randomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital, University/medical school/dental school
Study typeQuality of life, Treatment, Efficacy
Participant information sheet Not available in web format, please use the contact details to request a participant information sheet
Scientific titleEffects of transcranial direct current stimulation, mindfulness based stress reduction therapy, and cognitive functional therapy on pain intensity and disability in patients with non-specific chronic low back pain
Study objectivesHypotheses:
1. Transcranial direct current stimulation (tDCS) will be useful as an adjunctive treatment for non-specific chronic low back pain (NSCLBP).
2. Mindfulness-based stress reduction therapy (MBSR) will be useful as an adjunctive treatment for NSCLBP.
3. Cognitive functional therapy (CFT) will be useful as an adjunctive treatment for NSCLBP.
4. There is no difference in efficacy of tDCS, MBSR and CFT in treatment of NSCLBP.
Ethics approval(s)

Approved 27/01/2023, Ethics Committee (Swami Rama Nagar, P.O. Jolly Grant, Dehra Dun, 248016, India; +91 (0)135 2471111; research@srhu.edu.in), ref: SRHU/HIMS/ETHICS/2023/30

Health condition(s) or problem(s) studiedNon-specific chronic low back pain
InterventionParticipants were randomly allocated to either of the four groups using a computer generated random number sequence:
Group 1: standard medical treatment (pharmacological) (pain modification treatment)
Group 2: standard medical treatment and received 2 mA of direct current was delivered for 20 min via sponge electrodes 5 days per week for 2 consecutive weeks. The active electrode (anode) was placed over the primary motor cortex using the International 10–20 system contralateral to the side of the worst low back pain (LBP). The reference electrode (cathode) was positioned over the contralateral supraorbital region ipsilateral to the side of pain.
Group 3: standard medical treatment and group therapy was given to the participants in two groups (15 participants in each group). Duration of each session was between 90-120 minutes. Sessions were given weekly. A total of 8-10 sessions was given.
Group 4: standard medical treatment and individually tailored CFT sessions were given to the patients. Sessions ranged from 8-12 sessions over a period of 12 weeks.
Intervention typeMixed
Primary outcome measure1. Pain intensity measured using numeric rating scale at baseline (day 0), 3 months and 6 months
2. Disability measured using the Oswestry Disability Index at baseline (day 0), 3 months and 6 months
Secondary outcome measures1. Quality of life measured using RAND Sf36 questionnaire at baseline (day 0), 3 months and 6 months
2. Mindfulness assessed using Chronic Pain Acceptance Questionnaire, Mindfulness Awareness and Acceptance Questionnaire and Difficulty in Emotion Regulation scale within group 3 at baseline (day 0) and at 3 and 6 months from baseline
Overall study start date16/02/2022
Completion date30/03/2025

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit20 Years
Upper age limit55 Years
SexAll
Target number of participants160
Total final enrolment134
Key inclusion criteria1. Patients with NSCLBP
2. Aged between 20 and 55 years
3. Normal or minimal or non-specific changes on x-ray/MRI of lumbosacral spine
4. In case of multiple site pain, patient having low back pain as the most prominent presenting symptom
5. Patient who gives written informed consent
Key exclusion criteria1. Altered sensory or motor functions
2. Subjects with major painful comorbid medical conditions e.g., diabetic neuropathy, cancer, disc degeneration or prolapse, chronic kidney disease, chronic liver disease and other orthopaedic, rheumatological and painful neurological conditions
3. Any spine surgery in the preceding 6 months
4. Increased erythrocyte sedimentation rate (>30 mm/h)
5. Bone mineral density having t-score <-2.5
6. Specific psychiatric condition
7. Significant structural abnormality on imaging
Date of first enrolment31/01/2023
Date of final enrolment30/09/2024

Locations

Countries of recruitment

  • India

Study participating centre

Himalayan Institute of Medical Sciences
SRHU, Swami Rama Nagar, Jolly Grant
Dehardun
248016
India

Sponsor information

Funders

Funder type

University/education

Swami Rama Himalayan University
Private sector organisation / Universities (academic only)
Alternative name(s)
SRHU
Location
India

Results and Publications

Intention to publish date01/09/2026
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlans to publish in a peer-reviewed journal.
IPD sharing planThe datasets generated during and/or analysed during the current study will be available upon request from Vithika Singh (ptvithikasingh@gmail.com)

Editorial Notes

24/09/2025: Study's existence confirmed by Swami Rama Himalayan University.